Stock Ratings / Health Care / SBC / earnings

STLN (37) AHCO (45) SRTA (47) AUNA (61) ⌘ Pro Terminal →

SBC Medical Group Holdings Incorporated (SBC) Next Earnings Date & Expected ±10.6% Move

$5.69 +4.40% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

SBC Medical Group Holdings Incorporated (SBC) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (73% profit margin, 63% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B- • BUY Cap $585.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B-

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+5.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SBC)Realized 20D OHLCV Swing Band: ±10.6%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±10.6% Swing Band

±$0.60 Expected Swing

MODEL EARNINGS SETUP GAUGE

SBC Quantitative Pre-Earnings Setup: 71/100

Trailing EPS: $0.50 • YoY Revenue Growth: -15.5%

Model Bullish Setup (71/100)Model Risk Weight (29/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$173.6M	$51.0M	$23.3M	73.3%
FY 2024	2024-12-31	$205.4M	$46.6M	$18.0M	76%
FY 2023	2023-12-31	$193.5M	$39.4M	$50.7M	73.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating SBC & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on SBC
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SBC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +72.42%⚡ TESTING RESISTANCE

2026-10-30O $5.68H $5.70L $5.24C $5.69VOL 155.3K

RES: $5.89SUP: $2.99SMA50: $4.87SMA200: $3.91

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SBC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SBC Butterfly Map → + Track SBC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

1.6%/yr Implied 5Y Growth

vs. -15.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SBC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SBC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SBC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SBC)

Health Care Rank #87 of 1016 ⚔️ STLN vs SBC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SBC vs. STLN, AHCO, SRTA, AUNA)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, SBC Medical Group Holdings Incorporated (SBC) ranks #87 by composite RQD confidence (71/100, grade B-) and #425 by equity capitalization ($585.2M). Within this direct 5-issuer industry benchmark cohort, SRTA leads on earnings valuation at 10.2x trailing P/E, while SBC leads on capital efficiency and profitability with 63.1% ROIC and 73.3% gross margin. SBC currently leads its immediate peer cohort in composite quantitative strength at 71/100 (B-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SBC ACTIVE SBC Medical Group Holdings Incorporated	B-	71/100	11.5x	73.3%	63.1%	+4.40%	$585.2M	Benchmark Subject
STLN Starling Oncology Inc.	D-	37/100	—	—	-35.0%	+0.15%	$677.7M	/stln-vs-sbc →
AHCO AdaptHealth Corp.	D	45/100	—	18.8%	2.2%	-1.66%	$808.5M	/ahco-vs-sbc →
SRTA Strata Critical Medical Inc. (Class A)	D	47/100	10.2x	20.9%	-7.1%	-0.21%	$420.2M	/srta-vs-sbc →
AUNA Auna SA (Class A)	C-	61/100	—	—	—	+1.27%	$355.3M	/auna-vs-sbc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001930313

In its most recent audited fiscal period (FY2025, filed 2025-12-31), SBC Medical Group Holdings Incorporated (SBC) reported GAAP revenue of $173.6M (-15.5% vs. FY2024 revenue of $205.4M , and -10.3% cumulative change since FY2023) , GAAP net income of $51.0M, operating cash flow of $24.7M, and free cash flow of $23.3M (+29.1% YoY). On the balance sheet, SBC closed FY2025 with $380.4M in total assets against $0 in total debt (Altman Z-Score: 5.46, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$173.6M	$51.0M	$24.7M	$23.3M	$380.4M	—
FY2024 (FY)	2024-12-31	$205.4M	$46.6M	$20.6M	$18.0M	$266.1M	—
FY2023 (FY)	2023-12-31	$193.5M	$39.4M	$50.7M	$50.7M	—	—

3. SBC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SBC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $5.69 (+4.40% 1D, market cap $585.2M). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, SBC ranks #87 in composite RQD confidence.

How does SBC compare to STLN and AHCO in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), SBC carries a Roarable B- (71/100 RQD), trailing P/E of 11.5x, gross margin of 73.3%, and ROIC of 63.1%. By comparison, STLN (Starling Oncology Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $677.7M) and AHCO (AdaptHealth Corp.) posts a D grade (45/100 RQD, P/E N/A, ROIC 2.2%, cap $808.5M). Among the 5-stock peer group, SRTA leads on earnings multiple (10.2x) while SBC leads on capital efficiency (63.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SBC?

Per SBC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001930313), SBC Medical Group Holdings Incorporated generated $173.6M in revenue (-15.5% YoY), $51.0M in net income, and $23.3M in free cash flow against $380.4M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (73% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SBC trading relative to its 50-day, 200-day, and 52-week technical levels?

SBC last traded at $5.69 (+4.40% on volume of 258,973 shares), positioning the stock +16.84% above its 50-day simple moving average ($4.87) and +45.52% above its 200-day simple moving average ($3.91). Across its 52-week range of $2.78 to $5.79, SBC sits at the 96.7% percentile with a 14-day RSI of 51.8 (NEUTRAL RANGE) and an implied next-earnings move of ±10.6% ($5.09 to $6.29).

SBC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is SBC's next earnings date?

Based on SEC filing cadence, SBC Medical Group Holdings Incorporated (SBC)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is SBC stock expected to move on earnings?

Volatility modeling currently projects a ±10.6% event move for SBC, spanning a range between $5.09 and $6.29.

Direct Sub-Reports: SBC RQD Cockpit SBC 12M Forecast SBC Earnings & Move SBC Dividends & DRIP SBC Insiders & 13F SBC Whale Options SBC Profit Sankey SBC News & Why